TrialA Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Trial details
- Registry ID
- NCT04677179
- Phase
- Phase 2
Drug research
LY3471851
Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.
Drug identity checked against registry records
Also recorded as NKTR-358; REZPEG; Rezpegaldesleukin
A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.
Included trials
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)NCT04677179 | NKTR | Phase 2 | Terminated | 2022-08-09Actual |
| A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)NCT04433585 | NKTR | Phase 2 | Completed | 2023-01-10Actual |
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)
Trial details
- Registry ID
- NCT04433585
- Phase
- Phase 2
Regulatory dates and decisions
| No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed. |